(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. FGF9 requires VEGF signaling for the formation and maintenance of the
lung capillary network. (A-D) Incubation of E12.5 lung explants for
48 hours with 2.5 ng/µl FGF9 stimulates robust capillary formation (B)
compared with untreated lung (A). The VEGFR inhibitor SU5416 (45 µM)
eliminates the formation and survival of vessels (C). FGF9 is unable to
stimulate growth of new distal vessels in the presence of SU5416 (D) but can
partially rescue blood vessel survival in very proximal regions. (E-H)
FGF9 stimulates luminal dilation of the epithelial tubules (F). Branching
morphogenesis appears comparable to controls in SU5416-treated explants (G).
In contrast to capillary development, FGF9-induced luminal dilation is not
affected by SU5416 (H). Scale bar: 50 µm.